RY_SW01 Cell Injection Therapy in Systemic Sclerosis

Clinical trial NCT06058091 · RECRUITING

Trial details

NCT number: NCT06058091
Sponsor: Jiangsu Renocell Biotech Company
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 2023-09-22
Primary completion: 2025-12-31
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.